DIVIS LABORATORIES
|
The Current P/E Ratio of DIVIS LABORATORIES is 69.39.
Share Price | ₹6,026.6 | Sep 12,2025 |
Market Cap | ₹160,004.9 Cr | |
Earnings-TTM | ₹2,306.0 Cr | TTM-Consolidated Results |
Price/Earnings | 69.39x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of DIVIS LABORATORIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹160,004.9 Cr] as on Sep 12,2025
(/) Earnings [ ₹2,306.0 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 69.39x ]
Thus, for DIVIS LABORATORIES , the investors are currently willing to pay 69.39 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of DIVIS LABORATORIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of DIVIS LABORATORIES over the last five years.
Historical PE (Price/Earnings) ratio chart of DIVIS LABORATORIES
PE Ratio Performance Analysis for DIVIS LABORATORIES
- DIVIS LABORATORIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 51.17x.
- DIVIS LABORATORIES 's operated at median p/e ratio of 48.56x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, DIVIS LABORATORIES 's p/e ratio peaked in Mar2025 at 69.83x.
- DIVIS LABORATORIES 's p/e ratio hit its five-year low in Mar2022 of 39.49x.
How does DIVIS LABORATORIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
DIVIS LABORATORIES | 2,306.00 | 69.39 | 160,004.9 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 10,411.50 | 37.25 | 387,792.0 |
CIPLA LTD | 5,406.81 | 23.51 | 127,124.0 |
TORRENT PHARMACEUTICALS LTD | 2,002.00 | 60.29 | 120,700.0 |
DR REDDYS LABORATORIES LTD | 5,726.70 | 19.19 | 109,868.0 |
MANKIND PHARMA LTD | 1,905.51 | 55.88 | 106,486.0 |
ZYDUS LIFESCIENCES LTD | 4,637.80 | 22.67 | 105,136.0 |
LUPIN LTD | 3,722.18 | 25.07 | 93,301.2 |
AUROBINDO PHARMA LTD | 3,417.93 | 18.60 | 63,574.6 |
ABBOTT INDIA LTD | 1,452.29 | 45.30 | 65,794.9 |
ALKEM LABORATORIES LTD | 2,334.08 | 27.90 | 65,125.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs DIVIS LABORATORIES 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.60x |
Max industry PE | 69.39x |
Median industry PE | 27.90x |
Average industry PE | 36.82x |
You may also like the below Video Courses